| 1 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. PERRIGO UK FINCO LIMITED PARTNERSHIP et al |
2:17-cv-00754 |
D.N.J. |
|
|
|
|
| 2 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. PERRIGO UK FINCO LIMITED PARTNERSHIP et al |
2:17-cv-00754 |
D.N.J. |
|
|
|
|
| 3 |
LEO Pharma A/S et al v. Perrigo UK FINCO Limited Partnership et al |
1:16-cv-00430 |
D.Del. |
|
|
|
|
| 4 |
LEO Pharma A/S et al v. Perrigo UK FINCO Limited Partnership et al |
1:16-cv-00430 |
D.Del. |
|
|
|
|
| 5 |
LEO Pharma A/S et al v. Perrigo UK FINCO Limited Partnership et al |
1:16-cv-00430 |
D.Del. |
|
|
|
|
| 6 |
Endo Pharmaceuticals Solutions Inc. et al v. Custopharm Inc. |
1:14-cv-01422 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 7 |
Endo Pharmaceuticals Solutions Inc. et al v. Custopharm Inc. |
1:14-cv-01422 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 8 |
Endo Pharmaceuticals Solutions Inc. et al v. Custopharm Inc. |
1:14-cv-01422 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 9 |
Unimed Pharmaceuticals LLC et al v. Perrigo Company et al |
1:14-cv-01003 |
D.Del. |
|
|
|
|
| 10 |
Unimed Pharmaceuticals LLC et al v. Perrigo Company et al |
1:14-cv-01003 |
D.Del. |
|
|
|
|
| 11 |
MEDA PHARMACEUTICALS INC. v. PERRIGO ISRAEL PHARMACEUTICAL LTD. et al |
3:14-cv-01241 |
D.N.J. |
|
|
|
|
| 12 |
ELI LILLY AND COMPANY et al v. PERRIGO COMPANY et al |
1:13-cv-00851 |
S.D.Ind. |
|
|
|
|
| 13 |
ELI LILLY AND COMPANY et al v. PERRIGO COMPANY et al |
1:13-cv-00851 |
S.D.Ind. |
|
|
|
|
| 14 |
ELI LILLY AND COMPANY et al v. PERRIGO COMPANY et al |
1:13-cv-00851 |
S.D.Ind. |
|
|
|
|
| 15 |
Medicis Pharmaceutical Corporation v. Perrigo Israel Pharmaceuticals, Ltd. et al |
1:08-cv-00539 |
W.D.Mich. |
|
|
|
|
| 16 |
Unigen Pharmaceuticals Inc v. Perrigo Company et al |
3:08-cv-05258 |
W.D.Wash. |
|
|
|
|
| 17 |
MCNEIL-PPC, INC. v. PERRIGO COMPANY et al |
3:08-cv-01909 |
D.N.J. |
|
|
|
|
| 18 |
SCHERING CORPORATION v. PERRIGO COMPANY, et al |
2:02-cv-06087 |
D.N.J. |
|
|
|
|